Show items per page
Elements: 7
Page 1 on 1
 TitleAuthors / EditorsDate
add to browser selection
Tenofovir use is associated with a reduction in calculated glomerular filtration rates in the Swiss HIV Cohort Study Fux, C. A.; Simcock, Mathew; Wolbers, Marcel; Bucher, H. C.; ... Furrer, Hansjakob 2007
add to browser selection
Hypogonadism in HIV-1-infected men is common and does not resolve during antiretroviral therapy Wunder, D. M.; Bersinger, N. A.; Fux, C. A.; Mueller, N. J.; ... Furrer, Hansjakob 2007
add to browser selection
Tenofovir use is associated with an increase in serum alkaline phosphatase in the Swiss HIV Cohort Study Fux, C. A.; Rauch, Andri; Simcock, Mathew; Bucher, H. C.; ... Furrer, Hansjakob 2008
add to browser selection
Discontinuation of enfuvirtide in heavily pretreated HIV-infected individuals Elzi, Luigia; Kaufmann, Gilbert; Weber, Rainer; Fux, C. A.; ... Battegay, Manuel 2009
add to browser selection
Virological and immunological responses to efavirenz or boosted lopinavir as first-line therapy for patients with HIV Young, Jim; Bucher, H. C.; Guenthard, H. F.; Rickenbach, Martin; ... Battegay, Manuel 2009
add to browser selection
Low bone mineral density, renal dysfunction, and fracture risk in HIV infection: a cross-sectional study Calmy, Alexandra; Fux, C. A.; Norris, Richard; Vallier, Nathalie; ... Carr, Andrew 2009
add to browser selection
Implementation of raltegravir in routine clinical practice: selection criteria for choosing this drug, virologic response rates, and characteristics of failures Scherrer, A. U.; von Wyl, Viktor; Fux, C. A.; Opravil, Milos; ... Gunthard, Huldrych 2010